Literature DB >> 21901269

A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis.

Leonhard Lennertz1, Michael Wagner, Wolfgang Wölwer, Anna Schuhmacher, Ingo Frommann, Julia Berning, Svenja Schulze-Rauschenbach, Martin W Landsberg, Anja Steinbrecher, Michael Alexander, Petra E Franke, Ralf Pukrop, Stephan Ruhrmann, Andreas Bechdolf, Wolfgang Gaebel, Joachim Klosterkötter, Heinz Häfner, Wolfgang Maier, Rainald Mössner.   

Abstract

Mutations in postsynaptic scaffolding genes contribute to autism, thus suggesting a role in pathological processes in neurodevelopment. Recently, two de novo mutations in SHANK3 were described in schizophrenia patients. In most cases, abnormal SHANK3 genotype was also accompanied by cognitive disruptions. The present study queries whether common SHANK variants may also contribute to neuropsychological dysfunctions in schizophrenia. We genotyped five common coding or promoter variants located in SHANK1, SHANK2 and SHANK3. A comprehensive test battery was used to assess neuropsychological functions in 199 schizophrenia patients and 206 healthy control subjects. In addition, an independent sample of 77 subjects at risk for psychosis was analyzed for replication of significant findings. We found the T allele of the SHANK1 promoter variant rs3810280 to lead to significantly impaired auditory working memory as assessed with digit span (12.5 ± 3.6 vs. 14.8 ± 4.1, P < .001) in schizophrenia cases, applying strict Bonferroni correction for multiple testing. This finding was replicated for forward digit span in the at-risk sample (7.1 ± 2.0 vs. 8.3 ± 2.0, P = .044). Previously, altered memory functions and reduced dendritic spines and postsynaptic density of excitatory synapses were reported in SHANK1 knock-out mice. Moreover, the atypical neuroleptic clozapine was found to increase SHANK1 density in rats. Our findings suggest a role of SHANK1 in working memory deficits in schizophrenia, which may arise from neurodevelopmental changes to prefrontal cortical areas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901269     DOI: 10.1007/s00406-011-0233-3

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  37 in total

1.  Schizophrenia in a patient with subtelomeric duplication of chromosome 22q.

Authors:  P Failla; C Romano; A Alberti; A Vasta; S Buono; L Castiglia; D Luciano; D Di Benedetto; M Fichera; O Galesi
Journal:  Clin Genet       Date:  2007-06       Impact factor: 4.438

2.  Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1.

Authors:  Albert Y Hung; Kensuke Futai; Carlo Sala; Juli G Valtschanoff; Jubin Ryu; Mollie A Woodworth; Fleur L Kidd; Clifford C Sung; Tsuyoshi Miyakawa; Mark F Bear; Richard J Weinberg; Morgan Sheng
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

Review 3.  Working memory.

Authors:  Alan Baddeley
Journal:  Curr Biol       Date:  2010-02-23       Impact factor: 10.834

4.  De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.

Authors:  Julie Gauthier; Nathalie Champagne; Ronald G Lafrenière; Lan Xiong; Dan Spiegelman; Edna Brustein; Mathieu Lapointe; Huashan Peng; Mélanie Côté; Anne Noreau; Fadi F Hamdan; Anjené M Addington; Judith L Rapoport; Lynn E Delisi; Marie-Odile Krebs; Ridha Joober; Ferid Fathalli; Fayçal Mouaffak; Ali P Haghighi; Christian Néri; Marie-Pierre Dubé; Mark E Samuels; Claude Marineau; Eric A Stone; Philip Awadalla; Philip A Barker; Salvatore Carbonetto; Pierre Drapeau; Guy A Rouleau
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

5.  The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families.

Authors:  B A Cornblatt; N J Risch; G Faris; D Friedman; L Erlenmeyer-Kimling
Journal:  Psychiatry Res       Date:  1988-11       Impact factor: 3.222

6.  Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome).

Authors:  Christiane Zweier; Maarit M Peippo; Juliane Hoyer; Sergio Sousa; Armand Bottani; Jill Clayton-Smith; William Reardon; Jorge Saraiva; Alexandra Cabral; Ina Gohring; Koen Devriendt; Thomy de Ravel; Emilia K Bijlsma; Raoul C M Hennekam; Alfredo Orrico; Monika Cohen; Alexander Dreweke; Andre Reis; Peter Nurnberg; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-03-23       Impact factor: 11.025

Review 7.  The functional neuroanatomy of working memory: contributions of human brain lesion studies.

Authors:  N G Müller; R T Knight
Journal:  Neuroscience       Date:  2005-12-15       Impact factor: 3.590

8.  Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons.

Authors:  H M Critchlow; P R Maycox; J N Skepper; O Krylova
Journal:  Mol Cell Neurosci       Date:  2006-07-17       Impact factor: 4.314

9.  Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome.

Authors:  Vera M Kalscheuer; Ilse Feenstra; Conny M A Van Ravenswaaij-Arts; Dominique F C M Smeets; Corinna Menzel; Reinhard Ullmann; Luciana Musante; Hans-Hilger Ropers
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

10.  Novel de novo SHANK3 mutation in autistic patients.

Authors:  Julie Gauthier; Dan Spiegelman; Amélie Piton; Ronald G Lafrenière; Sandra Laurent; Judith St-Onge; Line Lapointe; Fadi F Hamdan; Patrick Cossette; Laurent Mottron; Eric Fombonne; Ridha Joober; Claude Marineau; Pierre Drapeau; Guy A Rouleau
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

View more
  12 in total

Review 1.  Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

Authors:  Andrea de Bartolomeis; Gianmarco Latte; Carmine Tomasetti; Felice Iasevoli
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

Review 2.  Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases.

Authors:  Felice Iasevoli; Carmine Tomasetti; Andrea de Bartolomeis
Journal:  Neurochem Res       Date:  2012-09-19       Impact factor: 3.996

Review 3.  Synapse assembly and neurodevelopmental disorders.

Authors:  Philip Washbourne
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

Review 4.  Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti
Journal:  Mol Neurobiol       Date:  2012-07-05       Impact factor: 5.590

Review 5.  Association of SHANK Family with Neuropsychiatric Disorders: An Update on Genetic and Animal Model Discoveries.

Authors:  Lily Wan; Du Liu; Wen-Biao Xiao; Bo-Xin Zhang; Xiao-Xin Yan; Zhao-Hui Luo; Bo Xiao
Journal:  Cell Mol Neurobiol       Date:  2021-02-17       Impact factor: 5.046

6.  The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment.

Authors:  Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro; Andrea de Bartolomeis
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

7.  Identification and functional characterization of rare SHANK2 variants in schizophrenia.

Authors:  S Peykov; S Berkel; M Schoen; K Weiss; F Degenhardt; J Strohmaier; B Weiss; C Proepper; G Schratt; M M Nöthen; T M Boeckers; M Rietschel; G A Rappold
Journal:  Mol Psychiatry       Date:  2015-01-06       Impact factor: 15.992

8.  Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.

Authors:  O R Homann; K Misura; E Lamas; R W Sandrock; P Nelson; S I McDonough; L E DeLisi
Journal:  Mol Psychiatry       Date:  2016-03-22       Impact factor: 15.992

Review 9.  Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.

Authors:  Viviana I Torres; Daniela Vallejo; Nibaldo C Inestrosa
Journal:  Neural Plast       Date:  2017-02-26       Impact factor: 3.599

10.  Translational Concepts of mGluR5 in Synaptic Diseases of the Brain.

Authors:  Thomas M Piers; Dong Hyun Kim; Byeong C Kim; Philip Regan; Daniel J Whitcomb; Kwangwook Cho
Journal:  Front Pharmacol       Date:  2012-11-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.